Wednesday, October 08, 2003

From the Akron (OH) Beacon Journal:
Rx Depot Case Pits Savings Against Safety
Shutting down a firm that links seniors with low-cost medication from Canada would create a "domino effect," leaving Americans nationwide without access to drugs they can afford, the company's lawyer told a federal judge during a hearing Wednesday.

U.S. District Judge Claire Eagan will decide whether to issue a nationwide injunction against a Tulsa-based chain of 85 storefronts that operate under the names Rx Depot and Rx of Canada.

From the Washington Post:
Hopefuls Back Drug Reimports
The Democratic presidential candidates say they support legalizing prescription drug purchases from Canada and Europe, which federal regulators and the pharmaceutical industry warn could be risky.

Their support of a House bill being negotiated in Congress comes as lawmakers and the Bush administration struggle to meet a self-imposed Oct. 17 deadline to approve a much broader Medicare prescription drug package.

From KOTV (OK):
Massachussets mayor in Tulsa to testify on behalf of RX Depot
"The FDA likes to say that this is a safety issue, well they're right. When I have to lay off firefighters, that's a safety issue; when I have to lay off police officers that's a safety issue. My prescription drug costs have gone up 100% in Springfield Massachusetts in 8 years."

Albano says Springfield will save enough money in one year to rehire dozens of laid-off police and fire personnel.

From the Montgomery (AL) Independent:
Local judge asked to stop cheap Rx firm
State regulators are asking a local judge to shut down a Huntsville distributor of Canadian prescription drugs, contending it's operating without a pharmacy license.

Don Copeland, co-owner of the targeted business, Canadian Options LLC, blames politics fueled by money from big American drug companies for the move.

From the Ottawa Citizen:
Study suggests antibiotic combo may slow progression of Alzheimer's
A combination of two inexpensive antibiotics could slow the heartbreaking spiral of mental decline experienced by people with Alzheimer's disease, a group of Canadian researchers is reporting.

Alzheimer's patients who took the drugs - doxycycline and rifampin - in combination for three months showed significantly slower cognitive decline at six months out from the start of the trial than patients who received a placebo, they will report at the annual meeting of the Infectious Disease Society of America in San Diego on Saturday.

No comments: